
New Ray Medicine International Holding Ltd.
6108.HKHKSEHealthcareMedical - Pharmaceuticals
最新資料
HK$0.225
+HK$0.016 · +7.66%
6108.HK公司概覽
盤中時間採用HKT。市場資料可能有所延遲。
公司概況
公司網站New Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.
- 產業
- Medical - Pharmaceuticals
- 部門
- Healthcare
- 總部
- CN
- 執行長
- Qiuqin Wang
- 上市以來
- 2013年10月28日
- 僱員
- 31
市場位置
52週區間
目前HK$0.225,
- 開盤價
- HK$0.225
- 前收盤價
- HK$0.209
- 成交量
- 7.2萬
- 0.79× 平均值
- 平均成交量
- 9.13萬
- 日均成交量
- 市值
- 4513.88萬 HKD
- 貝塔
- -3.94
- 市場參考 1
- 50天平均值
- HK$0.2061
- 高於平均水平+9.15%
- 200天平均值
- HK$0.2284
- 低於平均水平-1.49%
6108.HK同業公司
繼續GoAI的研究
在 GoAI 中研究6108.HKresearch.disclaimer





